Inactive Instrument

Analyst Reco. Nuvei Corporation

Equities

NVEI

CA67079A1021

Business Support Services

Analyst Reco.

Nuvei Brief: Proxy Advisor ISS Recommends Nuvei Shareholders Vote "FOR" Arrangement in Advance of the June 14, 2024	24-05-29	MT
Nuvei Brief: Board recommends shareholders vote "FOR" the Arrangement	24-05-14	MT
JPMorgan Downgrades Nuvei to Neutral From Overweight, Raises Price Target to $34 From $32	24-05-08	MT
Citigroup Raises Nuvei's Price Target to $34 From $23, Maintains Neutral Rating	24-04-03	MT
UBS Downgrades Nuvei to Neutral From Buy, Raises Price Target to $34 From $30	24-04-03	MT
Keefe Bruyette & Woods Downgrades Nuvei to Market Perform From Outperform, Adjusts PT to $34 From $31	24-04-02	MT
Seaport Global Downgrades Nuvei to Neutral From Buy	24-04-02	MT
Wolfe Research Downgrades Nuvei to Peer Perform From Outperform	24-04-02	MT
William Blair Downgrades Nuvei to Market Perform From Outperform	24-04-01	MT
Barclays Adjusts Price Target on Nuvei to $32 From $34, Maintains Overweight Rating	24-03-11	MT
UBS Raises Nuvei Price Target to $30 From $24, Maintains Buy Rating	24-03-07	MT
Wells Fargo Adjusts Price Target on Nuvei to $27 From $29, Maintains Equalweight Rating	24-03-07	MT
RBC Raises Price Target on Nuvei to $34 From $29, Keeps Outperform Rating	24-03-07	MT
Wells Fargo Starts Nuvei With Equalweight Rating, $29 Price Target	24-01-17	MT
Goldman Sachs Adjusts Price Target on Nuvei to $30 From $21, Maintains Neutral Rating	24-01-11	MT
Barclays Initiates Nuvei at Overweight Rating With $34 Price Target	23-12-20	MT
Nuvei Maintained at Outperform at BMO Following Analyst Switch; Price Target Kept at US$30.00	23-12-05	MT
Seaport Initiates Nuvei at Buy With $25 Price Target, Cites 'Intriguing Growth Profile at Reasonable Valuation'	23-11-30	MT
Goldman Sachs Adjusts Nuvei's Price Target to $21 From $19, Maintains Neutral Rating	23-11-09	MT
UBS Adjusts Nuvei Price Target to $24 From $20, Maintains Buy Rating	23-11-09	MT
UBS Initiates Coverage on Nuvei With Buy Rating, $20 Price Target	23-10-20	MT
Raymond James Trims Price Target on Nuvei to $27 From $28, Maintains Outperform Rating	23-10-17	MT
Goldman Sachs Adjusts Price Target on Nuvei to $19 From $22, Maintains Neutral Rating	23-10-12	MT
Goldman Sachs Adjusts Nuvei Price Target to $19 From $22, Maintains Neutral Rating	23-10-12	MT
Citigroup Adjusts Price Target on Nuvei to $20 From $42, Maintains Neutral Rating	23-09-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Nuvei Corporation

Equities

NVEI

CA67079A1021

Business Support Services

Analyst Reco.

Filters